Stock Taper 
STONEPINE CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Oruka Therapeutics, Inc. | ORKA | 7.5K | $713.77K |
 BioAge Labs Inc. | BIOA | 20K | $490.2K |
 Ultragenyx Pharmaceutical Inc. | RARE | 25K | $834.75K |
 MoonLake Immunotherapeutics | MLTX | 50K | $973.5K |
 Arvinas, Inc. | ARVN | 60K | $498.6K |
 Phathom Pharmaceuticals, Inc. | PHAT | 85.01K | $922.36K |
 Indivior Pharmaceuticals Inc | INDV | 100K | $4.1M |
 Nektar Therapeutics | NKTR | 120.65K | $8.42M |
 Humacyte, Inc. | HUMA | 231.3K | $180.51K |
 Zevra Therapeutics, Inc. | ZVRA | 258.7K | $3.71M |
 Heron Therapeutics, Inc. | HRTX | 490.79K | $209.47K |
 ADMA Biologics, Inc. | ADMA | 740K | $6.19M |
 Inovio Pharmaceuticals, Inc. | INO | 1.35M | $210.18K |
 Evolus, Inc. | EOLS | 1.59M | $11.04M |
 Verastem, Inc. | VSTM | 3.35M | $12.8M |